Blog Post

Our presentation at the GTC Boston Protein Discovery Summit

kbw • 7 December 2016

Ossianix had a presentation “ High-efficiency brain delivery of rituximab by fusion to an anti-TfR1 VNAR for MS and CNS lymphoma ” at the GTC Boston Protein Discovery Summit 2016.

You can download the abstract here .

< Older Post Newer Post >

Mail

Disclaimer

This website uses Google Analytics, a web analytics service provided by Google, Inc. (“Google”). Google Analytics uses “cookies”, which are text files placed on your computer to help the website analyse how visitors use the site. The information generated by the cookie about your use of the website (including your IP address) will be transmitted to and stored by Google on servers in the United States. Google will use this information for the purpose of evaluating your use of the website, compiling reports on website activity for website operators and providing other services relating to website activity and internet usage. Google may also transfer this information to third parties where required to do so by law, or where such third parties process the information on Google’s behalf. Google will not associate your IP address with any other data held by Google. You may refuse the use of cookies by selecting the appropriate settings on your browser, however please note that if you do this you may not be able to use the full functionality of this website. By using this website, you consent to the processing of data about you by Google in the manner and for the purposes set out above.

Share by: